Mesenchymal Stem Cell– tag –
-
Exreprotein Launches Animal-Derived Component-Free Cell Culture Supplement for Immune and Stem Cell Research, Enhancing Consistency and Performance
Product information/Industry review Unknown Overview Exreprotein has introduced the 'Exreprotein Cell Culture Supplemental Mix,' an advanced formulation specifically designed for immune and stem cell research. This supplement is chemical... -
BIANCA CLINIC Offers Autologous Adipose-Derived Stem Cell IV Therapy for Back Pain in Japan, Following Regenerative Medicine Regulatory Reforms
BIANCA CLINIC Japan Overview BIANCA CLINIC in Japan is offering intravenous (IV) therapy using autologous adipose-derived stem cells for back pain, aligning with Japan's legal framework reforms for regenerative medicine in 2025. This doc... -
Comprehensive Analysis Reveals iPSC Potential in CAR-T Therapy for Cancer, Highlights Key Challenges
Research Journal of Pharmacy and Technology India Overview A comprehensive review analyzes the therapeutic potential and inherent risks of hematopoietic stem cells (HSCs), mesenchymal stem cells (MSCs), and induced pluripotent stem cells... -
Japan Leads Global Stem Cell Research, Excels in Treatment Costs, Methods, and Safety
PlacidWay Japan Overview A PlacidWay infographic report highlights Japan as a global leader in regenerative medicine research, emphasizing its highly structured regulatory environment for stem cell therapy. Japan is particularly well-sui... -
Japan’s Stem Cell Therapy Landscape: High Costs and Strict MHLW Regulations Govern Regenerative Medicine Hubs
PlacidWay Japan Overview Leading stem cell therapy clinics in Japan, such as Cell Grand Clinic and Clinique Haru Osaka Umeda, offer regenerative medicine for conditions like joint disorders, musculoskeletal diseases, diabetes, and Parkin... -
Pectin-GPTMS Biomaterial Enables Sustainable 3D Bioprinting Scaffolds for Tissue Engineering, ACS Publications Reports
ACS Publications USA Overview ACS Publications announces the development of a novel pectin-GPTMS-based biomaterial as a promising platform for the sustainable manufacturing of 3D bioprinting scaffolds in tissue engineering. This research... -
Functional Polymer FP003B Maximizes Cell Yield in Microcarrier MSC Culture by Suppressing Aggregation, Frontiers Reports Breakthrough
Frontiers Switzerland Overview A new study in Frontiers proposes a breakthrough method using functional polymer 003B (FP003B) to significantly inhibit excessive aggregation of microcarriers/mesenchymal stromal cells (MSCs) and enhance ce... -
Japan Establishes Global Trust and Safety in Stem Cell Therapy Through Rigorous Act on the Safety of Regenerative Medicine (ASRM)
Grand Green Osaka Umekita Clinic Japan Overview Japan has solidified its position as a globally trusted nation for regenerative medicine, including stem cell therapy, through the 2014 Act on the Safety of Regenerative Medicine (ASRM). Th... -
Regenerative and Gene Therapies for Rare Diseases Achieve Key Clinical Milestones, Including iPSC for Retinitis Pigmentosa and Gene Therapy for Pediatric Hearing Loss
RegMedNet UK Overview Significant clinical milestones have been reached in regenerative and gene therapies for rare diseases. Sumitomo Pharma America has dosed the first patient in a Phase I/IIa trial of its iPSC-derived cell therapy for... -
AuctuPrime: AuctuCel’s Chemically Defined Medium Standardizes Cell Therapy Production, Slashing Variability
The Manila Times Philippines Overview Singapore-based AuctuCel, in collaboration with Sperikon, has launched AuctuPrime, a groundbreaking chemically defined cell culture medium. This next-generation formulation eliminates the need for an...
